La Jolla-based seed/early VC. $750M+ invested across 11 funds. Life sciences and tech. Founded by Kevin Kinsella. 125+ companies. Notable: Vertex, Synaptics, Vocera, Onyx Pharma. WSJ top biotech VC. [merged from 817]: San Diego's pioneering life sciences + tech VC. Founded 1983 by Kevin Kinsella. $750M+ deployed. Separate Avalon BioVentures fund ($135M, 2022) exclusively for early-stage biotech. Managing Partners: Jay Lichter, Sandy Madigan, Tighe Reardon. Accelerator model: incubates companies internally before bringing in co-investors. Notable: Erasca, Janux, Synthorx (acq. Sanofi $2.5B), Calporta (acq. Merck), Nerio (acq. Boehringer-Ingelheim $1.3B).

One of few VC firms investing primarily in defense technology. Menlo Park + San Diego offices. GP: Larsen Jensen. $125M fund (Dec 2023). 40+ companies. Deep SBIR expertise — helps portfolio from first SBIR contract through DoD scale. Close ties to Naval Base San Diego, Camp Pendleton, SOFWERX. Notable: Shield AI (early), Firestorm Labs, Kodiak ($50M Army project), Astranis, Solugen.

Corporate VC arm of Qualcomm. US, China, India, Israel, Europe, LatAm, Korea. Managing Directors: Quinn Li, Carlos Kokron. Focus: mobile, wireless, AI, IoT, semiconductor. Notable: Cloudflare, Fitbit, SentinelOne, Zoom, Magic Leap, Airspace, Braincorp, Wiliot.